Advertisement
Legal
Subscribe to Legal

The Lead

Mylan Files Patent Challenge Relating to BREVIBLOC(R)

November 25, 2014 11:07 am | News | Comments

Mylan has confirmed that it and several subsidiaries have been sued by several Baxter subsidiaries in connection with the filing of an Abbreviated New Drug Application (ANDA) with the FDA for Esmolol HCl in Sodium Chloride Injection.    

Does Bad Behavior Really Hurt Business?

November 24, 2014 8:41 am | by BARBARA ORTUTAY, AP Technology Writer | News | Comments

Google paid $500 million to settle a U.S. Justice Department investigation that alleged the...

Family Gets $6.75M in Botox Treatment Case

November 21, 2014 8:04 am | by DAVE GRAM, Associated Press | News | Comments

A New York couple who said Botox treatment of their son's cerebral palsy left him with life-...

Sucampo Files Patent Infringement Lawsuit Against Dr. Reddy's

November 13, 2014 8:45 am | News | Comments

Sucampo Pharmaceuticals has filed a patent infringement lawsuit against Dr. Reddy's Laboratories...

View Sample

FREE Email Newsletter

Dallas Hospital Reaches Deal with Ebola Victim's Family

November 12, 2014 9:09 am | Videos | Comments

The family of Ebola victim Thomas Eric Duncan has reached a settlement with Dallas Presbyterian Hospital. Also, the last remaining Ebola patient in the U.S., Dr. Craig Spencer, was released from the hospital.       

Pittsburgh Researcher Convicted of Poisoning Wife

November 10, 2014 2:45 pm | by JOE MANDAK, Associated Press | News | Comments

Jurors who convicted a University of Pittsburgh researcher of first-degree murder in the cyanide poisoning death of his wife say they didn't find his explanations believable and were moved by a 911 call.        

FDA Cracking Down on Dietary Supplement Company

November 10, 2014 8:54 am | Videos | Comments

The Food and Drug Administration is suing one company for allegedly failing to properly test its ingredients.                        

Advertisement

Ex-Pharma Exec Guilty of Manslaughter in Autistic Son's Death

November 6, 2014 1:33 pm | by JENNIFER PELTZ, Associated Press | News | Comments

A health care millionaire who fatally drugged her developmentally disabled son was convicted of manslaughter Wednesday in what her defense portrayed as a mercy killing by a mother trying to escape a labyrinth of fear and despair.    

Allergan Deal Inches Forward with Court's Decision

November 4, 2014 6:01 pm | by The Associated Press | News | Comments

In a win for Valeant and Pershing Square, a federal judge has decided that they can vote in takeover target Allergan's upcoming shareholder meeting.  Allergan said in a statement Tuesday that it will file an emergency appeal.    

Phoenix Man Gets Probation for Selling Fake Viagra

November 3, 2014 7:24 pm | News | Comments

A Phoenix man accused of selling fake sexual stimulation products online has been sentenced to two years of supervised probation. Maricopa County prosecutors say 68-year-old Melvin John Rutkowski was sentenced Monday for attempt to commit fraud schemes.

Stryker to Pay $1.43B to Settle Hip Implant Cases

November 3, 2014 7:14 pm | News | Comments

Medical implant maker Stryker will pay at least $1.43 billion to settle thousands of lawsuits from patients who had to have surgery to remove problematic hip implants.              

Actavis and Durata Therapeutics FTC Clearance for Actavis' Proposed Acquisition of Durata

November 2, 2014 5:34 pm | News | Comments

Actavis and Durata Therapeutics have  announced that the FTC has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to Actavis' pending acquisition of Durata.

Advertisement

New Bill in Japan Would Extend Sales Suspension of Quasi-Legal Drugs

November 2, 2014 5:28 pm | News | Comments

The ruling Liberal Democratic Party and its coalition partner have drawn up a draft amendment to the pharmaceutical affairs law that would extend the suspension of sales of quasi-legal drugs nationwide when a retailer is ordered to suspend sales of such drugs.

Lawsuit: Surgical Gowns Let Diseases Pass Through

October 31, 2014 2:39 pm | by ROBERT JABLON, Associated Press | News | Comments

A $500M lawsuit against Kimberly-Clark alleges the company falsely claimed its surgical gowns protected against Ebola and other infectious diseases. The suit alleges that the company knew for at least a year that its Microcool Breathable High Performance Surgical Gown had failed industry tests of impermeability to blood and microbes.

FTC Sues Gerber Over Claims on Infant Formula

October 30, 2014 2:02 pm | by ANNE FLAHERTY, Associated Press | News | Comments

Federal regulators announced Thursday they were suing Gerber, the well-known baby food maker, for claiming that its Good Start Gentle formula can prevent or reduce allergies in children.           

How Some Colored Contacts Could Permanently Damage Your Eyes

October 28, 2014 8:53 am | Videos | Comments

The U.S. government is working to seize all colored contacts not approved by the FDA.                            

Pfizer Wins SUTENT® Patent Case

October 23, 2014 10:14 am | News | Comments

Pfizer announced that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering SUTENT® capsules. This decision, which is subject to appeal, affirms Pfizer’s right to exclusively provide sunitinib malate as SUTENT to patients through the term of the patent, which expires in 2021.

Advertisement

Study Finds Drugs Still in Recalled Supplements

October 22, 2014 8:58 am | by LINDSEY TANNER, AP Medical Writer | News | Comments

Dietary supplements containing potentially dangerous prescription drug ingredients may still be for sale even years after safety recalls, a study found. In supplements bought online, researchers detected hidden steroids, similar ingredients to Viagra and Prozac and a weight loss drug linked with heart attacks.

German Firm Wins Appeal in Spain Thalidomide Case

October 22, 2014 8:13 am | News | Comments

A Spanish court has upheld an appeal by a German pharmaceutical company, ditching a previous ruling that ordered the company to pay compensation to 22 Spaniards who blame their disabilities on the drug thalidomide.      

Noven Files Patent Infringement Lawsuit Against Actavis

October 17, 2014 8:50 am | News | Comments

The lawsuit was filed as a result of Actavis submitting an Abbreviated New Drug Application to the FDA in which Actavis is seeking approval to market and sell a generic version of Brisdelle® capsules prior to the expiration of the patents.  

Supreme Court Weighs Generic Drug Dispute

October 15, 2014 1:28 pm | by SAM HANANEL, Associated Press | News | Comments

The Supreme Court seems divided as it considers a high-stakes patent dispute between rival pharmaceutical companies over the world's best-selling multiple sclerosis treatment.             

Merck Ex-Financial Analyst Facing Insider Trading Charge

October 15, 2014 8:14 am | News | Comments

A former senior finance analyst at Merck & Co. is facing an insider trading charge after authorities said Tuesday that he passed secrets to a friend he met at college that earned $722,000 in illegal profits.       

Sucampo Announces Extension of AMITIZA License and Collaboration Agreement With Takeda

October 14, 2014 9:08 am | News | Comments

Sucampo Pharmaceuticals has announced that it signed an amendment to the existing collaboration and license agreement covering the United States and Canada for AMITIZA with Takeda Pharmaceutical Company.        

Sucampo Settles AMITIZA Patent Litigation

October 10, 2014 8:21 am | News | Comments

Under the terms of the settlement, Sucampo and RTU will grant Par a non-exclusive license to market Par's generic version of lubiprostone 8 mcg soft gelatin capsule and 24 mcg soft gelatin capsule in the U.S. for the indications approved for AMITIZA beginning January 1, 2021, or earlier under certain circumstances.

Pharma Millionaire: I Didn't Force Meds Down Son's Throat

October 8, 2014 3:23 pm | by JENNIFER PELTZ, Associated Press | News | Comments

A pharmaceuticals millionaire charged with killing her developmentally disabled son in a deluxe hotel room told jurors Wednesday that she didn't force drugs down his throat, as prosecutors maintain. Taking the stand in her murder trial to give an account she's long yearned to tell, Gigi Jordan depicted a failed murder-suicide.

Safety Advocates Seek Stronger Warnings on Chantix

October 8, 2014 10:09 am | by MATTHEW PERRONE, AP Health Writer | News | Comments

Public safety advocates are asking the federal government to strengthen warnings on Pfizer's anti-smoking drug Chantix, even as the drugmaker prepares to argue that a bolded warning about psychiatric problems should be removed from its medicine's label.

Analyst: GSK's $490M Fine to Spark Pharma Strategy Shift in Emerging Markets

September 24, 2014 11:21 am | News | Comments

The scandal and its repercussions will be felt deep into Big Pharma’s operations in emerging markets, causing a fundamental shift in product marketing approaches involving physicians.           

For Victims, Johns Hopkins Settlement Marks a Step in Recovery

September 22, 2014 8:26 am | by JULIET LINDERMAN, Associated Press | News | Comments

A judge has finalized a $190 million settlement between Johns Hopkins Hospital and more than 8,000 patients of a gynecologist who used tiny cameras to secretly photograph women and girls during examinations.       

Judge to Hear Objections to Hopkins Settlement

September 19, 2014 8:25 am | by JULIET LINDERMAN, Associated Press | News | Comments

A Baltimore judge was set to hear objections Friday to a preliminary $190 million dollar settlement between Johns Hopkins Hospital System and more than 8,000 patients of a gynecologist who used tiny cameras to secretly photograph women and girls during examinations.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading